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Abstract Extracting biomedical information from large
metabolomic datasets by multivariate data analysis is of
considerable complexity. Common challenges include
among others screening for differentially produced
metabolites, estimation of fold changes, and sample clas-
siﬁcation. Prior to these analysis steps, it is important to
minimize contributions from unwanted biases and experi-
mental variance. This is the goal of data preprocessing. In
this work, different data normalization methods were
compared systematically employing two different datasets
generated by means of nuclear magnetic resonance (NMR)
spectroscopy. To this end, two different types of normali-
zation methods were used, one aiming to remove unwanted
sample-to-sample variation while the other adjusts the
variance of the different metabolites by variable scaling
and variance stabilization methods. The impact of all
methods tested on sample classiﬁcation was evaluated on
urinary NMR ﬁngerprints obtained from healthy volunteers
and patients suffering from autosomal polycystic kidney
disease (ADPKD). Performance in terms of screening for
differentially produced metabolites was investigated on a
dataset following a Latin-square design, where varied
amounts of 8 different metabolites were spiked into a
human urine matrix while keeping the total spike-in
amount constant. In addition, speciﬁc tests were conducted
to systematically investigate the inﬂuence of the different
preprocessing methods on the structure of the analyzed
data. In conclusion, preprocessing methods originally
developed for DNA microarray analysis, in particular,
Quantile and Cubic-Spline Normalization, performed best
in reducing bias, accurately detecting fold changes, and
classifying samples.
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1 Introduction
Nuclear magnetic resonance (NMR) spectroscopy is a
powerful and versatile method for the analysis of metab-
olites in biological ﬂuids, tissue extracts and whole tissues.
Applications include the analysis of metabolic differences
as a function of disease, gender, age, nutrition, genetic
background, and the targeted analysis of biochemical
pathways (Klein et al. 2011). Further, metabolomic data
derived from individuals with known outcome are used to
train computer algorithms for the prognosis and diagnosis
of new patients (Gronwald et al. 2011). There are many
good reviews available on these topics (Lindon et al. 2007;
Dieterle et al. 2011; Clarke and Haselden 2008).
Due to the chemical complexity of biological specimens
such as human urine and serum, which contain hundreds to
thousands of different endogenous metabolites and xeno-
biotics (Holmes et al. 1997), NMR spectra contain a cor-
respondingly large number of spectral features. Spectral
data are typically analyzed using multivariate data analysis
techniques (Wishart 2010), which all exploit the joint
distribution of the metabolomic data including the variance
of individual metabolite concentrations and their joint
covariance structure. Some sources of variation are the
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ment or metabolite concentrations between diseased indi-
viduals and controls. Other sources of variation are not
wanted and complicate the analysis. These include mea-
surement noise and bias as well as natural, non-induced
biological variability and confounders such as nutrition and
medication. An additional complication arises from the
typically large dynamic spectrum of metabolite concen-
trations. As described by van den Berg et al. (van den Berg
et al. 2006), one can expect order-of-magnitude differences
between components of metabolite ﬁngerprints of biolog-
ical specimens, where the highly abundant metabolites are
not necessarily more biologically important. Data normal-
ization needs to ensure that a measured concentration or a
fold change in concentration observed for a metabolite at
the lower end of the dynamic range is as reliable as it is for
a metabolite at the upper end. Also variances of individual
metabolite concentrations can differ greatly. This can have
a biological reason as some metabolites show large con-
centration changes without phenotypic effects, while others
are tightly regulated. Moreover, one observes that the
variance of non-induced biological variation often corre-
lates with the corresponding mean abundance of metabo-
lites leading to considerable heteroscedasticity in the data.
However, differences in metabolite variance can also have
technical reasons, because relative measurements of low
abundance metabolites are generally less precise than those
of high abundance metabolites. The goal of data prepro-
cessing is to reduce unwanted biases such that the targeted
biological signals are depicted clearly.
In accordance with the layout suggested by Zhang et al.
(Zhang et al. 2009), methods applicable to NMR spectra
may be grouped into (i) methods that remove unwanted
sample-to-sample variation, and (ii) methods that are
aimed at adjusting the variance of the different metabolites
to reduce for example heteroscedasticity. These include
variable scaling and variance stabilization approaches.
There are methods that attempt both tasks simultaneously.
The ﬁrst group includes approaches such as Probabilistic
Quotient Normalization (Dieterle et al. 2006), Cyclic Loess
Normalization (Cleveland and Devlin 1988; Dudoit et al.
2002), Contrast Normalization (Astrand 2003), Quantile
Normalization (Bolstad et al. 2003), Linear Baseline Nor-
malization (Bolstad et al. 2003), Li-Wong Normalization
(Li and Wong 2001), and Cubic-Spline Normalization
(Workman et al. 2002). The second group comprises
among others Auto Scaling (Jackson 2003) and Pareto
Scaling (Eriksson et al. 2004). These are so-called variable
scaling methods that divide each variable by a scaling
factor determined individually for each variable. The next
tested method of the second group is a non-linear trans-
formation that is aimed at the reduction of heteroscedas-
ticity by use of a Variance Stabilization Normalization
(Huber et al. 2002; Parsons et al. 2007; Durbin et al. 2002;
Anderle et al. 2011). Several of the aforementioned
methods, including Variance Stabilization Normalization,
were developed originally for the analysis of DNA
microarray data. Since factors complicating the analysis of
DNA microarray data also affect the analysis of meta-
bolomics data, it appeared promising to conduct a com-
prehensive evaluation of these methods for their
application to NMR-based metabolite ﬁngerprinting. A
similar evaluation, albeit limited to six linear scaling and
two heteroscedasticity reducing methods, had been already
performed for mass spectrometry based metabolomic data
(van den Berg et al. 2006).
For the evaluation of the performance of the different
data normalization methods in the identiﬁcation of differ-
entially produced metabolites and the estimation of fold
changes in metabolite abundance, we spiked eight endog-
enous metabolites at eight different concentration levels
into a matrix of pooled human urine following a Latin-
square design (Laywine and Mullen 1998) that keeps the
total spike-in amount constant while the molar amounts of
the individually added metabolites were varied. To inves-
tigate the effect of the different normalization methods on
sample classiﬁcation by a support vector machine (SVM)
with nested cross validation, a previously published dataset
comprising NMR urinary ﬁngerprints from 54 autosomal
polycystic kidney disease (ADPKD) patients and 46
apparently healthy volunteers was employed (Gronwald
et al. 2011).
2 Materials and methods
2.1 Urinary specimens
As a background for the spike-in data human spot-urine
specimens were collected from volunteers at the University
of Regensburg. Samples were pooled and immediately
frozen at -80 C until preparation for NMR analysis. The
classiﬁcation data had been generated previously employ-
ing urine specimens collected at the Klinikum Nu ¨rnberg
and the University Hospital Erlangen from 54 ADPKD
patients and 46 apparently healthy volunteers, respectively
(Gronwald et al. 2011).
2.2 Latin-square spike-in design
For the generation of the Latin-square spike-in data, eight
endogenous metabolites, namely 3-aminoisobutyrate, ala-
nine, choline, citrate, creatinine, ornithine, valine, and
taurine, were added in varied concentrations to eight ali-
quots of pooled human urine keeping the total concentra-
tion of metabolites added consistently at 12.45 mmol/l per
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individual metabolite was 6.25 mmol/l and was halved
seven times down to a minimum concentration
0.0488 mmol/l, i.e. in each of the 8 aliquots of urine each
metabolite was present at a different concentration. In
contrast to a dilution series, the overall concentration of the
contents remains the same, thus eliminating the impact of
differing total concentrations on normalization. The spike-
in samples were prepared once.
2.3 NMR spectroscopy
Toeach400-llspecimenofhumanurine200 llof0.1 mol/l
phosphate buffer, pH 7.4, and 50 ll of deuterium oxide
containing 0.75% (w/v) trimethylsilyl-2,2,3,3-tetradeu-
teropropionic acid (TSP) as a reference [Sigma-Aldrich,
Steinheim, Germany] were added. 1D
1H spectra were
measured as described previously (Gronwald et al. 2008)o n
a 600 MHz Bruker Avance III spectrometer [Bruker Bio-
Spin GmbH, Rheinstetten, Germany], which was equipped
with a cryogenic probe with z-gradients and a cooled auto-
matic sample changer. A 1D nuclear Overhauser enhance-
ment spectroscopy (NOESY) pulse sequence was used in all
cases and solvent signal suppression was achieved by pre-
saturation during relaxation and mixing time. All spectra
were measured once. Spectra were Fourier transformed and
phase corrected by automated routines. A ﬂat baseline was
obtained employing the baseopt option of TopSpin2.1
[BrukerBioSpin]thatcorrectstheﬁrstpointsoftheobserved
signal, i.e. of the free induction decay (FID). All spectra
were chemical shift referenced relative to the TSP signal.
For subsequent statistical data analysis, bin (feature) tables
were generated from the 1D
1H NMR spectra using AMIX
3.9 (Bruker BioSpin).
Signal positions between samples may be subject to
shifts due to slight changes in pH, salt concentration, and/
or temperature. In addition, the TSP signal used for spectral
referencing may also show pH-dependent shifts. Here we
chose to use equidistant binning to compensate for these
effects, which is still the most widely used method. In order
to keep a clear focus on data normalization other param-
eters of metabolomic data evaluation such as the initial
data processing including spectral binning were kept con-
stant. Competing methods include peak alignment (Forshed
et al. 2003; Stoyanova et al. 2004), approaches working at
full resolution using statistical total correlation spectros-
copy (Cloarec et al. 2005a), and orthogonal projection to
latent structures (Cloarec et al. 2005b). In another approach
termed targeted proﬁling a pre-selected set of metabolites
is quantiﬁed from 1D spectra and these values are used for
subsequent data analysis (Weljie et al. 2006). Quantitative
values may also be obtained from 2D spectra (Lewis et al.
2007; Gronwald et al. 2008). For the data presented here an
optimized bin size of 0.01 ppm was applied and bins were
generated in the regions from 9.5 to 6.5 ppm and from 4.5
to 0.5 ppm, respectively, to exclude the water artifact and
the broad urea signal, leaving 701 bins for further analysis.
To correct for variations in urine concentration, all data in
the classiﬁcation data set was linearly scaled to the signal
of the CH2 group of creatinine at 4.06 ppm. This can be
considered as normalization in itself. Each dataset was
arranged in a data matrix X = (xij) with i = 1…I and
I = 701 representing the feature or bin number, and
j = 1…J with J = 8 and J = 100 for the spike-in and
classiﬁcation datasets, respectively, representing the num-
ber of specimens. For further analysis, tables were impor-
ted into the statistical analysis software R version 2.9.1
(Development Core Team 2011).
2.4 Basic characteristics of the normalization
algorithms employed
For all normalization methods discussed it is assumed that
NMR signal intensities scale linearly with metabolite
concentration and are mostly independent of the chemical
properties of the investigated molecules. The equations
describing the different normalization approaches are listed
in Supplemental Table S1. The ﬁrst group of methods
evaluated aims to reduce between-sample variations. If not
stated otherwise, it is assumed in the following that only a
relatively small proportion of the metabolites is regulated
in approximately equal shares up and down. The ﬁrst group
includes the following approaches:
Probabilistic Quotient Normalization (Dieterle et al.
2006) assumes that biologically interesting concentration
changes inﬂuence only parts of the NMR spectrum, while
dilution effects will affect all metabolite signals. In case of
urine spectra, dilution effects are caused, for example, by
variations in ﬂuid intake. Probabilistic Quotient Normali-
zation (PQN) starts, with an integral normalization of each
spectrum, followed by the calculation of a reference
spectrum such as a median spectrum. Next, for each vari-
able of interest the quotient of a given test spectrum and
reference spectrum is calculated and the median of all
quotients is estimated. Finally, all variables of the test
spectrum are divided by the median quotient.
Cyclic Locally Weighted Regression (Cyclic Loess) is
based on MA-plots, which constitute logged Bland-Altman
plots (Altman and Bland 1983). The presence of non-linear
such as intensity-depended biases is assumed. Brieﬂy, the
logged intensity ratio M of spectra j1 and j2 is compared to
theiraverageAfeaturebyfeature(Dudoitetal.2002).Then,a
normalizationcurve is ﬁttedusing non-linear local regression
(loess) (Cleveland and Devlin 1988). This normalization
curve is subtracted from the original values. If more than two
spectra need to be normalized, the method is iterated in pairs
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convergence is reached after two cycles. If only a relatively
small proportion of the metabolites are regulated, all data
points can be taken into account. Otherwise, rank-invariant
metabolites can be selected for the computation of the loess
lines. Here, all data points were used.
Contrast Normalization also uses MA-plots (Astrand
2003) and makes the same assumptions as Cyclic Loess.
The data matrix of the input space is logged and trans-
formed by means of an orthonormal transformation matrix
T = (tij) into a contrast space. This expands the idea of
MA-plots to several dimensions and converts the data into
a set of rows representing orthonormal contrasts. A set of
normalizing curves is then ﬁtted similarly to those in
Cyclic Loess Normalization, using a robust distance mea-
sure e based on the Euclidean norm that renders the nor-
malization procedure independent of the particular choice
of T. The contrasts are then evened out by a smooth
transformation, ensuring that features with equal values
prior to normalization retain identical values. Subse-
quently, data are mapped back to the original input space.
The use of a log function impedes the handling of negative
values and zeros. Therefore, all non-positive values were
set beforehand to a residual value (10
-11) three orders of
magnitude smaller than the smallest value in the original
data. Subtracting the 10%-quantile from each spectrum will
minimize the bias introduced thereby.
The goal of Quantile Normalization is to achieve the
same distribution of feature intensities across all spectra.
Similarity of distributions can be visualized in a quantile–
quantile plot (Bolstad et al. 2003). If two spectra share the
same distribution, all quantiles will be identical and, hence,
align along the diagonal. The idea is to bring simply all
spectra to an identical distribution of intensities across
features (bins). This is achieved by sorting the vector of
feature intensities in ascending order separately for each
spectrum. In the sorted vector each entry corresponds to a
quantile of the distribution. Next the mean of identical
quantiles across spectra is calculated, i.e. the mean of the
highest abundances, the mean of the second highest
abundances, and so on. This mean is assigned to all fea-
tures that realize the corresponding quantile. For example,
the feature with the highest intensity in a spectrum is
assigned the average of the highest intensities across
spectra irrespectively of their spectral positions. Since
different features may display the highest intensity in dif-
ferent samples, this constant average value may be
assigned to different features across samples. After Quan-
tile Normalization the vectors of feature intensities consist
of the same set of values, however, these values are dis-
tributed differently among features.
A completely different normalization approach used in
DNA microarray analysis is Baseline Scaling. In contrast to
normalizing the data to a measure of the full dataset, here
the data is normalized only to a subset of it, the so-called
baseline. This can be conducted both linearly and non-
linearly. Typically, the spectrum with the median of the
median intensities is chosen as baseline, but other choices
are possible, too. Alternatively, an artiﬁcial baseline can be
constructed.
Linear Baseline Scaling uses a scaling factor to map
linearly from each spectrum to the baseline (Bolstad et al.
2003). Therefore, one assumes a constant linear relationship
between each feature of a given spectrum and the baseline.
In the version implemented in this paper, the baseline is
constructed by calculating the median of each feature over
all spectra. The scaling factor b is computed for each spec-
trum as the ratio of the mean intensity of the baseline to the
mean intensity of the spectrum. Then, the intensities of all
spectra are multiplied by their particular scaling factors.
However, the assumption of a linear correlation between
spectra may constitute an oversimpliﬁcation.
A more complex approach is to ﬁt a Non-Linear Base-
line Normalization relationship between the spectra that are
to be normalized and the baseline as implemented by Li
and Wong (2001). It is assumed that features corresponding
to unregulated metabolites have similar intensity ranks in
two spectra, allowing a reliable determination of a nor-
malization curve. In addition, possible non-linear rela-
tionships between the baseline and the individual spectra
are assumed. The normalization process is based on scatter
plots with the baseline spectrum (having the median overall
intensity) on the x-axis and the spectrum to be normalized
on the y-axis. Ideally, the data should align along the
diagonal y = x. As the non-normalized data generally
deviates from that, the normalization curve is then ﬁtted to
map the data to the diagonal. To make sure that the nor-
malization curve is ﬁtted only on non-differentially
expressed features, a set of almost rank-invariant features
(invariant set) is calculated and used for ﬁnding the nor-
malizing piecewise linear running median line.
Another non-linear baseline method makes use of Cubic
Splines (Workman et al. 2002). As in quantile normaliza-
tion the aim is to obtain a similar distribution of feature
intensities across spectra. In this method as well the exis-
tence of non-linear relationships between baseline and
individual spectra are assumed. A baseline, called target
array in the original publication that corresponds to a target
spectrum here, is built by computing the geometric mean of
the intensities of each feature over all spectra. In this paper,
the geometric mean was substituted by the arithmetic mean
for reasons of robustness to negative values. For normali-
zation, cubic splines are ﬁtted between each spectrum and
the baseline. To that end, a set of evenly distributed
quantiles is taken from both the target spectrum and the
sample spectrum and used to ﬁt a smooth cubic spline. This
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by a small offset each time. Next, a spline function gen-
erator uses the generated set of interpolated splines to ﬁt
the parameters of a natural cubic spline (B-spline). Here,
for each spectrum ﬁve iterations comprising 14 quantiles
each were calculated and interpolated to normalize the
data.
The second group of methods is aimed at adjusting the
variance of different metabolites. These include variable
scaling and variance stabilization approaches. The simplest
of these approaches uses the standard deviation of the data
as a scaling factor. This method is called Auto Scaling or
unit variance (uv) scaling (Jackson 2003). It results in
every feature displaying a standard deviation of one, i.e.
the data is transformed to standard units. Brieﬂy, one
centers the data ﬁrst by subtracting from each feature its
mean feature intensity across spectra. This will result in a
ﬂuctuation of the data around zero, thereby adjusting for
offsets between high and low intensity features. From the
centered data the standard deviation of each feature is
obtained and data is divided by this scaling factor. Auto
Scaling renders all features equally important. However,
measurement errors will also be inﬂated and between-
sample variation due to dilution effects, which in case of
urine spectra are caused, for example, by variations in ﬂuid
intake will not be corrected.
Using the square root of the standard deviation is an
alternative used by Pareto Scaling (Eriksson et al. 2004). It
is similar to Auto Scaling, but its normalizing effect is less
intense, such that the normalized data stays closer to its
original values. It is less likely to blow up noisy back-
ground and reduces the importance of large fold changes
compared to small ones. However, very large fold changes
may still show a dominating effect.
Variance Stabilization Normalization (VSN) transfor-
mations are a set of non-linear methods that aim to keep the
variance constant over the entire data range (Huber et al.
2002; Parsons et al. 2007; Durbin et al. 2002; Anderle et al.
2011). In the VSN R-package used here (Huber et al.
2002), a combination of methods that corrects for between-
sample variations by linearly mapping all spectra to the
ﬁrst spectrum followed by adjustment of the variance of
the data is applied. Looking at the non-normalized data, the
coefﬁcient of variation, i.e. the variance divided by the
corresponding mean, does not vary much for the strong and
medium signals, implying that the standard deviation is
proportional to the mean and, therefore, in VSN it is
assumed that the variance of a feature depends on the mean
of that feature via a quadratic function. But as values
approach the lower limit of detection, variance does not
decrease any more, but rather stays constant, thus, the
coefﬁcient of variation increases. VSN addresses exactly
this problem by using the inverse hyperbolic sine. This
transformation approaches the logarithm for large values,
therefore removing heteroscedasticity. For small intensi-
ties, though, it approaches linear transformation behavior,
leaving the variance unchanged. The VSN normalized data
is not logged again for comparisons based on logarithmic
intensities of the data.
The R-code for performing the different normalization
techniques is given in the supplemental material.
2.5 Classiﬁcation of samples using a support vector
machine
Classiﬁcation of samples was performed using the support
vector machine (SVM) provided in the R-library e1071
(http://cran.r-project.org/web/packages/e1071). Results were
validated by a nested cross-validation approach that consists
of an inner loop for model ﬁtting and parameter optimization
and an outer loop for assessment of classiﬁcation perfor-
mance. From the analyzed dataset of 100 urine specimens
two samples were selected arbitrarily and excluded to serve
as test data of the outer cross-validation (leave-two-out
cross-validation). Then, two of the remaining samples were
chosen randomly and put aside to serve as test data of the
inner cross-validation. In the inner loop, the SVM was
trained on the remaining n - 4 samples in order to ﬁnd the
optimal number of features. For this, the feature number
k was increased stepwise within the range k = 10…60. The
top k features with the highest t-values were selected and a
SVM classiﬁer was trained and applied to the left-out
samples of the inner loop.
For each feature number, the SVM was trained (n - 2)/
2 times, such that every sample except for the outer test
samples was used once as inner test sample. The accuracy
on the inner test samples was assessed and the optimal
feature number was used to train classiﬁers in the outer
loop. In the outer cross-validation, the SVM was trained on
all samples except the outer test samples, using the optimal
number of features from the inner loop and the outer test
samples were predicted. This was repeated n/2 times, so
that all samples were chosen once as outer test data. In all
cases a linear kernel was used. In all steps feature selection
was treated as part of the SVM training and was redone
excluding left out cases for every iteration of the cross
validations.
Classiﬁcation performance was analyzed by evaluating
receiver operating characteristic (ROC) plots that had been
obtained by using the R-package ROCR (Sing et al. 2005).
3 Results and discussion
A ﬁrst overview of the data (Data Overview) was obtained
by comparing the densities of the metabolite concentration
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classiﬁcation dataset. Supplemental Fig. S1 shows the
creatinine adjusted-intensity distributions. For comparison,
the distribution of the Quantile normalized data that rep-
resents an average of the intensity distributions is indicated
in red. Roughly similar distributions were obtained for all
specimens.
Next we investigated for each normalization method
whether comparable proﬁles were obtained for all samples
of the classiﬁcation dataset (Overall between Sample
Normalization Performance). To that end, all preprocess-
ing methods were included, although the variable scaling
and variance stabilization methods are not speciﬁcally
designed to reduce between-sample variation. For all fea-
tures we calculated the pair-wise differences in intensity
between spectra. We argue, that if these differences do not
scatter around zero, this is evidence that for one out of a
pair of spectra the concentrations are estimated systemat-
ically either too high or too low. To assess the performance
of methods we calculated for each pair-wise comparison
the ratio of the median of differences to the inter-quartile
range (IQR) of differences and averaged the absolute val-
ues of these ratios across all pairs of samples (average
median/IQR ratios). Dividing by the IQR ensures that the
differences are assessed on comparable scales. The smaller
the average median/IQR ratios are the better is the global
between-sample normalization performance of a method.
The results for the classiﬁcation dataset are shown in the
ﬁrst row of Table 1.
Comparing the list of average median/IQR ratios, PQN
(0.04), Quantile (0.06), Cyclic Loess (0.06), VSN (0.07),
and Cubic Spline (0.07) reduced overall differences
between samples the best compared to the creatinine-nor-
malized data only (0.46). The other methods, except for
Contrast and Li-Wong Normalization, all improved the
comparability between samples, but did not perform as
well as the methods mentioned above. Note that the two
variable scaling methods performed similarly and, there-
fore, were summarized as one entry in Table 1. The good
performance of the VSN method can be explained by the
fact that VSN combines variance stabilization with
between-sample normalization. In comparison to the
creatinine-normalized data, Auto and Pareto Scaling also
showed some improvement.
While good between-sample normalization is desirable,
it should not be achieved at the cost of reducing the gen-
uine biological signal in the data. We tested for this in the
Latin-square data. By experimental design, all intensity
ﬂuctuations except for those of the spiked-in metabolites,
which should stand out in each pair-wise comparison of
spectra, are caused by measurement imprecision. That is,
spike-in features must be variable, while all other features
should be constant. We assessed this quantitatively by
calculating the IQR of the spike-in feature intensities and
dividing it by the IQR of the non-spike-in feature intensi-
ties (average IQR ratios). These ratios are given in the
second row of Table 1. High values indicate a good sepa-
ration between spiked and non-spiked data points and,
therefore, are favorable.
For the non-normalized data a ratio of 5.12 was
obtained, i.e. the spike-in signal stood out clearly. These
results were also obtained for the PQN and the Linear
Baseline methods. For the Cyclic Loess, Quantile, Cubic
Spline, Contrast, VSN, and Li-Wong approaches, the ratio
was slightly reduced demonstrating that normalization
might affect the true signals to some extent. Nevertheless,
the signal-to-noise ratios for these methods were still above
4 and the signals kept standing out.
Importantly, Auto and Pareto Scaling compromised the
signal-to-noise ratio severely. As for the classiﬁcation data,
the two variable scaling methods performed comparable
and were summarized as one entry.
This prompted us to investigate systematically technical
biases in this data (Analysis of intensity-dependent
bias). As illustrated in Fig. 1a and b, M versus rank(A)-
plots (M-rank(A)-plots) allow the identiﬁcation of inten-
sity-dependent shifts between pairs of feature vectors. Data
in M-rank(A)-plots are log base 2 transformed so that a fold
change of two corresponds to a difference of one. For each
feature, its difference in a pair of samples (y-axis) is plotted
against the rank of its mean value (x-axis). Hence, the
x-axis corresponds to the dynamic spectrum of feature
intensities, while the y-axis displays the corresponding
variability of the intensities.
Table 1 Analysis of average inter- and intra-sample differences by means of interquartile ranges
Crea-
normalized/
non-normalized
PQN Cyclic loess Contrast Quantile Linear
baseline
Li-Wong Cubic
spline
Auto/
pareto
scaling
VSN
Average median/IQR ratios 0.46 0.04 0.06 0.55 0.06 0.15 0.82 0.07 0.28 0.07
Average IQR ratios 5.12 5.12 4.13 4.69 4.31 5.12 3.37 4.46 0.82 4.95
First row: Average ratios of the median to the IQR of the classiﬁcation data. Lower values are favorable. Second row: Average ratios of the IQR
of the spiked features to the IQR of the non-spiked features. Here, higher values are favorable. The two variable scaling methods performed
equally and, therefore, are summarized in a single column
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investigated normalization methods, M-rank(A)-plots were
produced from the classiﬁcation data as well as from the
Latin-square data. Representative sets of plots for a ran-
domly selected pair of spectra selected from each of the
two datasets are displayed in Fig. 1a and b. Shown are
plots for creatinine-normalized classiﬁcation data, respec-
tively non-normalized Latin-square data and for data after
Cyclic Loess, Quantile and Cubic Spline Normalization. In
the absence of bias, the points should align evenly around
the straight line at M = 0. The additionally computed loess
line (curved line) represents a ﬁt of the data and helps to
determine how closely the data approaches M = 0.
In the M-rank(A) plots of creatinine-normalized
(Fig. 1a) and non-normalized data (Fig. 1b), the curved
loess line clearly does not coincide with the straight line at
M = 0. The plot of the creatinine-normalized classiﬁcation
data in Fig. 1a suggests that intensities in sample 2 of the
pair are systematically overestimated at both ends of the
dynamic spectrum but not in the middle. One might want to
attribute this observation to a technical bias in the mea-
surements. While we cannot proof directly that the obser-
vation originates indeed from a technical bias rather than
biological variation, we will show later that correction for
the effect improves the estimation of fold changes, the
detection of differentially produced metabolites and the
classiﬁcation of samples.
Here, we ﬁrst evaluated the normalization methods with
respect to their performance in reducing such an effect.
Looking at Cyclic Loess normalized data in Fig. 1a, the
bias is gone for the mid and high intensities, however, in
the low-intensity region additional bias is introduced
affecting up to 20% of the data points. With Quantile and
Cubic Spline Normalization nearly no deviation from
M = 0 can be recognized in Fig. 1a, they seem to remove
any bias almost perfectly. Similar trends were also
observed for the other pair-wise comparisons within the
classiﬁcation data (plots not shown). Application of the
other normalization methods to the classiﬁcation data
showed that PQN and VSN evened out most bias well,
although they sometimes left the loess line s-shaped. The
linear baseline method performed similarly, in that it only
partially reduced bias. Contrast, Li-Wong and the two
variable scaling methods hardly reduced bias at all.
The M-Rank(A) plots of the Latin-square data, of which
4 examples are shown in Fig. 1b, generally resemble those
obtained for the classiﬁcation data, except for one major
difference: Here, we have a large amount of differential
spike-in features representing a range of 2- to 128-fold
changes. The spike-in differences should not be lost to
normalization. Therefore, for better visualization, all
empirical data points of the spiked-in metabolites were
marked differently, while the non-differential data points
were marked in black (Fig. 1b). Ideally, all data points
corresponding to the spiked-in metabolites should all be
found in the high- and mid-intensity range (A). Moreover,
differences (M) should increase with increasing spike-in
concentrations, resulting in a triangle-like shaped distri-
bution of the data points corresponding to the spiked-in
metabolites and the curved loess line staying close to
M = 0. As expected, the spike-ins stood out clearly in
the non-normalized data. This was also the case for the
PQN, Cyclic Loess, Contrast, Quantile, Linear Baseline,
Li-Wong, Cubic Spline and VSN normalized data but not
for the variable scaling normalized data.
The performance of all methods with respect to cor-
recting dynamic range related bias can be compared in
Loess-Line Plots (Bolstad et al. 2003). In these plots we
drew rank(A) (x-axis) against the differences of the average
loess line to the baseline at M = 0( y-axis). The average
loess line was computed for each normalization method by
a loess ﬁt of the absolute loess lines of the Ranked MA-
plots for all pairs of NMR spectra. Our plots are a variation
of those used by Bolstad et al. (2003) and (Keeping and
Collins 2011) in that we use rank(A) instead of A on the
x-axis. Any local offset from zero indicates that the nor-
malization method does not work properly in the corre-
sponding part of the dynamic range.
We calculated these plots for both the classiﬁcation data
(Fig. 2a) and the spike-in data (Fig. 2b). Since in most
cases similar trends were obtained for both datasets, the
best performing methods will be discussed together if not
stated otherwise. In the absence of normalization, an
increasing offset with decreasing intensities is observed for
the lower ranks of both datasets. Cyclic Loess Normali-
zation reduced the distance for the mid intensities well, but
it increased the offset for low intensities. Contrast, Quantile
and VSN Normalization all removed the intensity-depen-
dency of the offset well. Regarding the overall distance,
Quantile Normalization reduced it best, followed by VSN.
Contrast Normalization left the distance at a rather large
value. Taken together, this analysis shows that intensity-
dependent measurement bias can only be corrected by a
few normalization approaches. Not surprisingly, these are
methods that model the dynamic range of intensities
explicitly.
M-rank(A)-plots can also detect unwanted heterosced-
asticity, which may compromise the comparability of
intensity changes across features. Spreading of the point
cloud at one end of the dynamic range, as exempliﬁed by
the solely creatinine-normalized and non-normalized data,
respectively, in Fig. 1a and b, indicates a decrease in the
reliability of measurements. In the absence of evidence that
these effects reﬂect true biology or are due to spike-ins
(data points corresponding to spiked-in metabolites in
Fig. 1b), one should aim at correcting this bias. Otherwise
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123Fig. 1 a M-rank(A)-plots
comparing the same randomly
selected pair of specimens from
the classiﬁcation dataset after
creatinine normalization alone
(top left) and after additional
Cyclic Loess (top right),
Quantile (lower left), and Cubic
Spline Normalization (lower
right). The straight line
indicates M = 0, the curved line
represents a loess ﬁt of the data
points. Deviations of the loess
line from M = 0 correlate with
bias between samples. The data
is log base 2 transformed so that
a fold change of two
corresponds to a difference of
one. b The same methods as
above were applied to a pair of
samples from the Latin-square
spike-in dataset. Note, that for
this dataset no prior creatinine
normalization was performed
and, therefore, in the top left
part of the Figure results
obtained from non-normalized
data are displayed. The black
dots represent background
features that should not vary,
while the differently marked
dots, mostly found on the right
hand side, represent features for
which spike-in differences are
expected. Therefore, they
preferably stand out from the
non-spike-in background
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123Fig. 2 Ranked plot of the
averaged loess line versus
intensity A of the classiﬁcation
(a) and the spike-in (b) datasets
for all normalization
approaches. The lines were
computed for each
normalization method by a loess
ﬁt of the absolute loess lines of
the M-rank(A)-plots for all
sample pairs. Smaller and
intensity-independent distances
are preferable. The data is log
base 2 transformed. For the
methods involving centering not
all features are well deﬁned
after logarithmic transformation
leading to shorter average loess
lines. Solid lines depict methods
that are aimed at reducing
sample-to-sample variations,
while variable scaling and
variance stabilization
approaches are marked
by dashed lines
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123feature lists ranked by fold changes might be dominated by
strong random ﬂuctuations at the ends of the dynamic
spectrum. Between-feature comparability will only be
achieved, if the standard deviation of feature intensities is
kept low over the entire dynamic spectrum.
The inﬂuence of the different normalization techniques
on standard deviation relative to the dynamic spectrum was
investigated using plots of the standard deviation for both
the classiﬁcation (Fig. 3a) and the Latin-square dataset
(Fig. 3b). For this, the standard deviation of the logged data
in a window of features with similar average intensities
was plotted versus the rank of the averaged feature inten-
sity, similarly to Irizarry et al. (Irizarry et al. 2003). The
plots show for both the creatinine-normalized (Fig. 3a) and
the non-normalized data (Fig. 3b), respectively, that stan-
dard deviation decreases with increasing feature intensity.
The same is true for the PQN normalized data. Further,
VSN keeps the standard deviation fairly constant over the
whole intensity regime. In contrast, Li-Wong increases the
standard deviation compared to the non-normalized data.
The two variable scaling approaches increase standard
deviation substantially.
Next, we investigated the inﬂuence of preprocessing on
the detection of metabolites produced differentially, the
estimation of fold changes from feature intensities, and the
classiﬁcationofsamplesbasedonurinaryNMRﬁngerprints.
IntheLatin-squaredata,weknowbyexperimentaldesign
which features have different intensities and which do not.
The goal of the following analysis is to detect the spike-in
related differences and to separate them from random ﬂuc-
tuations among the non-spiked metabolites (Detection of
Fold Changes). To that end, features with expected spike-in
signals were identiﬁed and separated from background fea-
tures.Excludedwerefeaturesthatwereaffectedbythetailof
spike-in signals, and regions in which several spike-in sig-
nals overlaid. As the background signal in the bins contain-
ing spike-in signals was, in general, not negligible, it was
subtractedtoavoiddisturbancesinthefoldchangemeasures.
Then, all feature intensities in all pairs of samples were
compared and fold changes were estimated. Fold changes
that resulted from a spike-in were ﬂagged. Next, the entire
list of fold changes was sorted. Ideally, all ﬂagged fold
changes should rank higher than those resulting from ran-
dom ﬂuctuations. In reality, however, ﬂagged and non-
ﬂagged fold changes mix to some degree. Obviously, by
design smaller spike-in fold changes tend to be surpassed
by random ﬂuctuations. The ﬂagging was performed with
three different foci, ﬁrst ﬂagging all spike-in features, then
just low spike-in fold changes up to three and last only high
fold changes above ten.
Receiving operator characteristic (ROC) curves with
corresponding area under the curve (AUC) values were
calculated for each normalization method and are given in
Supplemental Table S2. Looking at the AUC values, only
four methods yielded consistently better classiﬁcation
results than those obtained with the non-normalized data:
Contrast, Quantile, Linear Baseline, and Cubic Spline
Normalization. Quantile Normalization reached the highest
AUC values in all runs, Cubic Spline and the Linear
Baseline method showed comparable results and Contrast
Normalization performed slightly better than the non-nor-
malized data.
Fig. 3 Plot of the logged standard deviation within the features
versus the rank of the averaged feature intensity of the classiﬁcation
(a) and spike-in (b) datasets. To make the ﬁt less sensitive to outliers,
lines were computed using a running median estimator. The data is
log base 2 transformed. Solid lines depict methods that are aimed at
reducing sample-to-sample variations, while variable scaling and
variance stabilization approaches are marked by dashed lines
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123Differentially produced metabolites may be detected
correctly even if the actual fold changes of concentrations
are systematically estimated incorrectly. The ROC curves
depend only on the order of fold changes but not on the
actual values. This can be sufﬁcient in hypothesis gener-
ating research but might be problematic in more complex
ﬁelds such as metabolic network modeling. Therefore, we
evaluated the impact of the preprocessing techniques on the
accurate determination of fold changes. Based on published
reference spectra, for each metabolite a set of features
corresponding to the spike-in signals was determined,
features with overlapping spike-in signals were removed
and the background signal was subtracted. Within this set
of features, the feature with the highest measured fold
change among all pairs of samples with the highest
expected fold change was chosen for evaluating the accu-
racy of determining the actual fold change for the respec-
tive metabolite. Note that the spike-in metabolite creatinine
was excluded because of the absence of any non-overlap-
ping spike-in bins. Then, plots of the spike-in versus the
measured fold changes between all pairs of samples were
computed for each metabolite and each normalization
method. For taurine, Fig. 4 shows exemplary results
obtained from non-normalized data and from data after
Cyclic Loess, Quantile, and Li-Wong Normalization,
respectively.
In analogy to Bolstad et al. (2003) the following linear
model was used to describe the observed signal x of a bin
i and a sample j:
logxij ¼ clogc0 þ clogcspike-in þ eij ð1Þ
Here, c0 denotes the signal present without spike-in, cspike-
in the spike-in concentration of the respective metabolite, c
the proportionality between signal intensity and spike-in
concentration, which is assumed to be concentration
independent within the linear dynamic range of the NMR
spectrometer, and eij the residual error.
Comparing two samples j1 and j2 leads to the following
linear equation, for which we estimate the intercept a and
the regression slope b,
log
xij1
xij2
¼ a þ blog
cspike-in1
cspike-in2
ð2Þ
In Supplemental Table S3, slope estimates b for the
different metabolites and normalizations are given. Again
the variable scaling methods were summarized in a single
entry. It is obvious that nearly all values exceed one,
meaning that the fold changes are overestimated. This can
be explained by the choice of features: As one metabolite
generally contributes to several features and the feature
with the highest fold change between the pair of samples
with the highest spike-in difference is selected for each
metabolite, features overestimating the fold change are
preferred over features underestimating or correctly
estimating the fold change. However, we still favored
this automated selection algorithm over manually
searching for the ‘‘nicest looking’’ bin, to minimize
effects of human interference.
Apart from that, it can be seen from an analysis of the
slope estimates b that normalization performs quite dif-
ferently for different metabolites. The methods that showed
the most uniform results for all metabolites investigated are
Quantile, Contrast, Linear Baseline, and Cubic Spline
Normalization.
In Supplemental Table S4, values for the intercept a, the
slope b, and the coefﬁcient of determination R
2 are given,
averaged over all metabolites. The data shows that the
methods that performed best in estimating accurately fold
changes are Quantile and Cubic Spline Normalization.
Another common application of metabolomics is the
classiﬁcation of samples. To investigate the degree to
which the different normalization methods exerted an
effect on this task, the dataset consisting of the ADPKD
patient group and the control group was used. Classiﬁca-
tions were carried out using a support vector machine
(SVM) with a nested cross-validation consisting of an inner
loop for parameter optimization and an outer loop for
assessing classiﬁcation performance (Gronwald et al.
2011). The nested cross-validation approach yields an
almost unbiased estimate of the true classiﬁcation error
(Varma and Simon 2006). For the nested cross validation, a
set of n samples was selected randomly from the dataset.
This new dataset was then normalized and classiﬁcations
were performed as detailed above. Classiﬁcation perfor-
mance was assessed by the inspection of the corresponding
ROC curves (Supplemental Fig. S2). The classiﬁcation was
conducted ﬁve times for every normalization method and
classiﬁcation dataset size n.
In Table 2, the AUC values and standard deviations of
the ROC curves are given for all normalization methods
and classiﬁcation dataset sizes of n = 20, n = 40, n = 60,
n = 80, and n = 100, respectively. As expected, the clas-
siﬁcation performance of most normalization methods
depended strongly on the size of the training set used for
classiﬁcation. The method with the highest overall AUC
value was Quantile Normalization: With 0.903 for
n = 100, 0.854 for n = 80, and 0.812 for n = 60, it per-
formed the best among the normalization methods tested,
albeit for larger dataset sizes only. For dataset sizes
n B 40, its performance was about average. Cubic-Spline
Normalization performed nearly as well as Quantile Nor-
malization: It yielded the second highest AUC values for
the larger training set sizes of n = 100 (0.892) and n = 80
(0.841). In contrast to Quantile Normalization, it also
performed well for smaller dataset sizes: For n = 20
(0.740), it was the best performing method. VSN also
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size range, its AUC values were barely inferior to those of
the Cubic-Spline Normalization. Cyclic Loess performed
almost as well as Quantile Normalization. For small dataset
sizes, its classiﬁcation results were only slightly better than
average, but for the larger dataset sizes it was among the
best-performing methods. Over the whole dataset size
range, the classiﬁcation results of PQN, Contrast and the
Linear Baseline Normalizations and those of the variable
scaling methods were similar to results obtained with cre-
atinine-normalized data. Supplemental Table S5 gives the
median (ﬁrst column) and the mean number (second col-
umn) of features used for classiﬁcation with respect to the
applied normalization method. As can be seen, the number
of selected features strongly depended on the normalization
method used. The best performing Quantile Normalization
led to a median number of 21 features, while the applica-
tion of Cubic Spline Normalization and VSN resulted in
the selection of 27 and 34 features, respectively. Employ-
ment of the PQN approach and the variable scaling
methods resulted for the most part in a greater number of
selected features without improving classiﬁcation perfor-
mance. The third column of Supplemental Table S5 gives
the percentage of selected features that are identical to
those selected by SVM following Quantile Normalization.
As can be seen, PQN yielded about 95% of identical fea-
tures, followed by Li-Wong and the Linear Baseline
method with approx. 90% identical features. This data
shows that the ranking of features based on t-values, which
was the basis for our feature selection, is only moderately
inﬂuenced by normalization. The smallest percentage
(52.4%) of identical features was observed for Contrast
Normalization, which also performed the poorest overall
(Table 2).
We also investigated the impact of the use of creatinine
as a scale basis for renal excretion by subjecting the clas-
siﬁcation data to direct normalization by Quantile and
Cubic-Spline Normalization without prior creatinine nor-
malization. For n = 100, AUC values of 0.902 and 0.886
were obtained for Quantile and Cubic-Spline Normaliza-
tion, respectively. These values are very similar to those
obtained for creatinine-normalized data, which had been
0.903 and 0.892 for Quantile and Cubic-Spline Normali-
zation, respectively. However, without prior creatinine–
normalization an increase in the average number of
selected features was noticed, namely from 21 to 31 and 27
to 36 features, respectively, for Quantile and Cubic-Spline
Normalization. In summary one can say that Quantile and
Cubic-Spline Normalization are the two best performing
methods with respect to sample classiﬁcation irrespective
whether prior creatinine normalization has been performed
or not.
Different preprocessing techniques have also been
evaluated with respect to the NMR analysis of metabolites
Fig. 4 Plot of the
reproducibility of determining
spike-in fold changes for taurine
from the Latin-square spike-in
dataset without normalization
(upper left), after Cyclic Loess
(upper right), Quantile (lower
left) and Li-Wong
Normalization (lower right).
Features at the border of the
spike-in signal frequencies are
represented by grey dots ,
whereas features from the inner
range of the signals are plotted
black. As detailed in the text,
for each metabolite one feature
was automatically selected.
These features (marked
differently) were used for ﬁtting
a linear model, which is given in
the upper left corner of each
plot. The solid lines represent
the actual models, while the
dashed lines represent ideal
models with a slope of 1 and an
intercept of 0. The data is log
base 2 transformed
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123in blood serum (de Meyer et al. 2010). Especially, Integral
Normalization, where the total sum of the intensities of
each spectrum is kept constant, and PQN were tested in
combination with different binning approaches. PQN fared
the best, but it was noted that none of the methods tested
yielded optimal results, calling for improvements in both
spectral data acquisition and preprocessing. The PQN
technique was also applied to the investigation of NMR
spectra obtained from cerebrospinal ﬂuid (Maher et al.
2011).
Several of the preprocessing techniques compared here
have been also applied to mass spectrometry-derived
metabolomic data and proteomics measurements. Van den
Berg et al. (2006) applied 8 different preprocessing
methods to GC-MS data. These included Centering, Auto
Scaling, Range Scaling, Pareto Scaling, Vast Scaling,
Level Scaling, Log Transformation and Power Transfor-
mation. They found, as expected, that the selection of the
proper data pre-treatment method depended on the bio-
logical question, the general properties of the dataset and
the subsequent statistical data analysis method. Despite
these boundaries, Auto Scaling and Range Scaling
showed the overall best performance. For the NMR
metabolomic data presented here, the latter two methods
were clearly outperformed by Quantile, Cubic Spline and
VSN Normalization, all of which were not included in the
analysis of the GC-MS data. In the proteomics ﬁeld,
Quantile and VSN normalization are commonly employed
(Jung 2011).
4 Concluding remarks
In this study, normalization methods, different in aim,
complexity and origin, were compared and evaluated using
two distinct datasets focusing on different scientiﬁc chal-
lenges in NMR-based metabolomics research. Our main
goal was to give researchers recommendations for
improved data preprocessing.
A ﬁrst ﬁnding is that improper normalization methods
can signiﬁcantly impair the data. The widely used variable
scaling methods were outperformed by Quantile Normali-
zation, which was the only method to perform consistently
well in all tests conducted. It removed bias between sam-
ples, and accurately reproduced fold changes. Its only ﬂaw
was its mediocre classiﬁcation result for small training sets.
Therefore, we recommend it for dataset sizes of n C 50
samples.
For smaller datasets, Cubic Spline Normalization rep-
resents an appropriate alternative. We showed that its bias
removal and fold change reproduction properties were
nearly equal to Quantile Normalization. Moreover, it
classiﬁed well irrespectively of the dataset size.
VSN also represents a reasonable choice. Concerning
the ADPKD data, it showed good results for both classi-
ﬁcation and bias removal. Concerning the spike-in data it
performed less convincingly; however, the spike-in design
affects the normalization procedure strongly by inducing
additional variance. In conclusion, we found that prepro-
cessing methods originally developed for DNA microarray
analysis performed superior.
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Table 2 Classiﬁcation performance measured on classiﬁcation dataset
Normalization n = 20 n = 40 n = 60 n = 80 n = 100
Crea-normalized 0.628 ± 0.074 0.722 ± 0.037 0.776 ± 0.032 0.783 ± 0.019 0.787 ± 0.003
PQN 0.710 ± 0.029 0.749 ± 0.034 0.781 ± 0.018 0.802 ± 0.016 0.796 ± 0.002
Cyclic loess 0.683 ± 0.029 0.728 ± 0.030 0.784 ± 0.027 0.797 ± 0.012 0.859 ± 0.005
Contrast 0.611 ± 0.072 0.693 ± 0.046 0.718 ± 0.036 0.764 ± 0.018 0.757 ± 0.004
Quantile 0.688 ± 0.023 0.731 ± 0.043 0.812 ± 0.033 0.854 ± 0.009 0.903 ± 0.003
Linear baseline 0.661 ± 0.034 0.728 ± 0.020 0.777 ± 0.027 0.790 ± 0.019 0.756 ± 0.005
Li-Wong 0.607 ± 0.036 0.659 ± 0.024 0.723 ± 0.043 0.771 ± 0.029 0.804 ± 0.005
Cubic spline 0.740 ± 0.066 0.749 ± 0.040 0.793 ± 0.018 0.841 ± 0.010 0.892 ± 0.003
Auto 0.705 ± 0.032 0.703 ± 0.020 0.764 ± 0.020 0.772 ± 0.011 0.789 ± 0.006
Pareto 0.652 ± 0.037 0.717 ± 0.038 0.757 ± 0.032 0.796 ± 0.010 0.785 ± 0.008
VSN 0.721 ± 0.022 0.772 ± 0.013 0.790 ± 0.015 0.838 ± 0.009 0.887 ± 0.003
Averaged AUC values and their standard deviation for the classiﬁcation performance obtained for different sizes of the classiﬁcation dataset and
following different normalization methods. In all cases a SVM with nested cross-validation was employed
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